These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1110 related items for PubMed ID: 25738570

  • 1. A Systematic Review on the Efficacy of Amlodipine in the Treatment of Patients With Hypertension With Concomitant Diabetes Mellitus and/or Renal Dysfunction, When Compared With Other Classes of Antihypertensive Medication.
    Jeffers BW, Robbins J, Bhambri R, Wajsbrot D.
    Am J Ther; 2015; 22(5):322-41. PubMed ID: 25738570
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of Calcium Channel Blockers Versus Other Classes of Antihypertensive Medication in the Treatment of Hypertensive Patients With Previous Stroke and/or Coronary Artery Disease: A Systematic Review and Meta-Analysis.
    Jeffers BW, Robbins J, Bhambri R.
    Am J Ther; 2017; 24(1):e68-e80. PubMed ID: 26588586
    [Abstract] [Full Text] [Related]

  • 3. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H, Lu Z, Tang WL, Pang LW, Wang GM, Wong GW, Wright JM.
    Cochrane Database Syst Rev; 2015 Jan 11; 1():CD008170. PubMed ID: 25577154
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological interventions for hypertension in children.
    Chaturvedi S, Lipszyc DH, Licht C, Craig JC, Parekh R.
    Evid Based Child Health; 2014 Sep 11; 9(3):498-580. PubMed ID: 25236305
    [Abstract] [Full Text] [Related]

  • 5. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S, Lipszyc DH, Licht C, Craig JC, Parekh RS.
    Evid Based Child Health; 2014 Sep 11; 9(3):581-3. PubMed ID: 25236306
    [Abstract] [Full Text] [Related]

  • 6. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril.
    Wright JT, Dunn JK, Cutler JA, Davis BR, Cushman WC, Ford CE, Haywood LJ, Leenen FH, Margolis KL, Papademetriou V, Probstfield JL, Whelton PK, Habib GB, ALLHAT Collaborative Research Group.
    JAMA; 2005 Apr 06; 293(13):1595-608. PubMed ID: 15811979
    [Abstract] [Full Text] [Related]

  • 7. Prior Medications and the Cardiovascular Benefits From Combination Angiotensin-Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High-Risk Hypertensive Patients.
    Brook RD, Kaciroti N, Bakris G, Dahlöf B, Pitt B, Velazquez E, Weber M, Zappe DH, Hau T, Jamerson KA.
    J Am Heart Assoc; 2018 Jan 04; 7(1):. PubMed ID: 29301757
    [Abstract] [Full Text] [Related]

  • 8. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Davis BR, Piller LB, Cutler JA, Furberg C, Dunn K, Franklin S, Goff D, Leenen F, Mohiuddin S, Papademetriou V, Proschan M, Ellsworth A, Golden J, Colon P, Crow R, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group.
    Circulation; 2006 May 09; 113(18):2201-10. PubMed ID: 16651474
    [Abstract] [Full Text] [Related]

  • 9. Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs--overview and meta-analyses.
    Thomopoulos C, Parati G, Zanchetti A.
    J Hypertens; 2015 Feb 09; 33(2):195-211. PubMed ID: 25485720
    [Abstract] [Full Text] [Related]

  • 10. Nebivolol for the Treatment of Essential Systemic Arterial Hypertension: A Systematic Review and Meta-Analysis.
    Seleme VB, Marques GL, Mendes AEM, Rotta I, Pereira M, Júnior EL, da Cunha CLP.
    Am J Cardiovasc Drugs; 2021 Mar 09; 21(2):165-180. PubMed ID: 32710438
    [Abstract] [Full Text] [Related]

  • 11. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.
    Psaty BM, Lumley T, Furberg CD, Schellenbaum G, Pahor M, Alderman MH, Weiss NS.
    JAMA; 2003 May 21; 289(19):2534-44. PubMed ID: 12759325
    [Abstract] [Full Text] [Related]

  • 12. Comparison of amlodipine versus other calcium channel blockers on blood pressure variability in hypertensive patients in China: a retrospective propensity score-matched analysis.
    Zhang L, Yang J, Li L, Liu D, Xie X, Dong P, Lin Y.
    J Comp Eff Res; 2018 Jul 21; 7(7):651-660. PubMed ID: 29888950
    [Abstract] [Full Text] [Related]

  • 13. Antihypertensive pharmacogenetic effect of fibrinogen-beta variant -455G>A on cardiovascular disease, end-stage renal disease, and mortality: the GenHAT study.
    Lynch AI, Boerwinkle E, Davis BR, Ford CE, Eckfeldt JH, Leiendecker-Foster C, Arnett DK.
    Pharmacogenet Genomics; 2009 Jun 21; 19(6):415-21. PubMed ID: 19352213
    [Abstract] [Full Text] [Related]

  • 14. The Role of Beta-Blockers in the Treatment of Hypertension.
    Cruickshank JM.
    Adv Exp Med Biol; 2017 Jun 21; 956():149-166. PubMed ID: 27957711
    [Abstract] [Full Text] [Related]

  • 15. Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 14 - effects of different classes of antihypertensive drugs in older and younger patients: overview and meta-analysis.
    Thomopoulos C, Parati G, Zanchetti A.
    J Hypertens; 2018 Aug 21; 36(8):1637-1647. PubMed ID: 29847487
    [Abstract] [Full Text] [Related]

  • 16. Adult hypertension: reducing cardiovascular morbidity and mortality.
    Prescrire Int; 2005 Feb 21; 14(75):25-33. PubMed ID: 15751180
    [Abstract] [Full Text] [Related]

  • 17. Blood pressure treatment levels and choice of antihypertensive agent in people with diabetes mellitus: an overview of systematic reviews.
    Brunström M, Eliasson M, Nilsson PM, Carlberg B.
    J Hypertens; 2017 Mar 21; 35(3):453-462. PubMed ID: 27870655
    [Abstract] [Full Text] [Related]

  • 18. Effects of blood pressure-lowering treatment. 6. Prevention of heart failure and new-onset heart failure--meta-analyses of randomized trials.
    Thomopoulos C, Parati G, Zanchetti A.
    J Hypertens; 2016 Mar 21; 34(3):373-84; discussion 384. PubMed ID: 26780184
    [Abstract] [Full Text] [Related]

  • 19. Effects of Long- and Intermediate-Acting Dihydropyridine Calcium Channel Blockers in Hypertension: A Systematic Review and Meta-Analysis of 18 Prospective, Randomized, Actively Controlled Trials.
    Chaugai S, Sherpa LY, Sepehry AA, Kerman SRJ, Arima H.
    J Cardiovasc Pharmacol Ther; 2018 Sep 21; 23(5):433-445. PubMed ID: 29739234
    [Abstract] [Full Text] [Related]

  • 20. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.
    JAMA; 2000 Apr 19; 283(15):1967-75. PubMed ID: 10789664
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.